OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi
Thaila Fernanda dos Reis, Patrícia Alves de Castro, Rafael Wesley Bastos, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36

Showing 26-50 of 36 citing articles:

Identifying Fast and Slow-Acting Antimalarial Compounds of Pandemic Response Box Against Blood-Stage Culture of Plasmodium falciparum 3D7
Vinoth Rajendran, Nimitha Cherthedath Naveen
Current Microbiology (2024) Vol. 81, Iss. 3
Closed Access

Milteforan, a promising veterinary commercial product against feline sporotrichosis
Laura C. García Carnero, Thaila Fernanda dos Reis, Camila Diehl, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Peptides antimicrobiens : une nouvelle alternative pour le traitement des aspergilloses
Camille Rochard, Jeanne Bigot, Viviane Balloy, et al.
Revue des Maladies Respiratoires (2024) Vol. 41, Iss. 4, pp. 283-288
Closed Access

Brilacidin, a host defense peptide mimetic, potentiates ibrexafungerp antifungal activity against the human pathogenic fungusAspergillus fumigatus
Thaila Fernanda dos Reis, Camila Diehl, Camila Figueiredo Pinzan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Brilacidin, a novel antifungal agent againstCryptococcus neoformans
Camila Diehl, Camila Figueiredo Pinzan, Patrícia Alves de Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Fungi: friends or foes—an outreach science initiative for the collection of airborne fungal spores by high school students
Daryna Piontkivska, João M. P. Jorge, Rita Neves, et al.
Journal of Microbiology and Biology Education (2024) Vol. 25, Iss. 2
Open Access

Brilacidin, a host defense peptide mimetic, potentiates ibrexafungerp antifungal activity against the human pathogenic fungus Aspergillus fumigatus
Thaila Fernanda dos Reis, Camila Diehl, Camila Figueiredo Pinzan, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access

Investigating the Antimicrobial Potential of 560 Compounds from the Pandemic Response Box and COVID Box against Resistant Gram-Negative Bacteria
Rita de Cássia Cerqueira Melo, Aline Andrade Martins, Andressa Leite Ferraz de Melo, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 723-723
Open Access

Screening of the Pandemic Response Box library identified promising compound candidate drug combinations against extensively drug-resistant Acinetobacter baumannii
Nonlawat Boonyalai, Dutsadee Peerapongpaisarn, Chatchadaporn Thamnurak, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Decoding molecular mechanism of species-selective targeting of fungal versus human HSP90 using multiple replica molecular dynamics simulations and binding free energy calculations
Jinying Cheng, Xue Yin, Lulu Wang, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 22, pp. 12478-12488
Closed Access

Antistaphylococcal discovery pipeline; where are we now?
Daria Nawrot, Weronika Ambrożkiewicz-Mosler, Martin Doležal, et al.
European Journal of Medicinal Chemistry (2023) Vol. 266, pp. 116077-116077
Closed Access

Previous Page - Page 2

Scroll to top